MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Aging"

  • 2017 International Congress

    Parkinsonism in the very old – A clinicopathological study

    A. Rajput, E. Rajput (Saskatoon, SK, Canada)

    Objective: To identify, spectrum of Parkinson variants, clinical features and course of disease in age > 80 year onset cases. Background: Old age is the…
  • 2017 International Congress

    Beneficial and Protective Effects of Withania Someniferais On Mice Brain: A Therapeutic Potential Drug for Parkinson’s Disease

    S. Rajput, S. Sinha (New Delhi, India)

    Objective: Objective of our study was evaluate effect of  Withania Someniferais leaves on Parkinsons brain of mice  Background: Parkinson’s disease (PD), an age-related disorder, is…
  • 2017 International Congress

    Salivary Alpha-Synuclein in Aging

    G. Vivacqua, A. Fabbrini, A. Suppa, R. Mancinelli, G. Fabbrini, C. Colosimo, A. Berardelli (Rome, Italy)

    Objective: We measured alpha-synuclein total (a-syntotal) and alpha-synuclein oligomers (a-synolig) concentration in 70 healthy subjects, of different ages (from 18 to 88 years old) to…
  • 2016 International Congress

    Treating Parkinson’s 2015–A nationwide survey of treatment responses and complications in 1000 Irish patients with Parkinson’s disease

    C. Stubbe, P. Bogdanova-Mihaylova, N. Kavanagh, K. Mulpeter, D. Bradley, T. Lynch, T. Counihan, P. Brown, S. O'Sullivan, R.A. Walsh (Dublin, Ireland)

    Objective: To collect real-life data from a large cohort with Parkinson's disease (PD), with particular emphasis on drug regimens, motor complications, and quality of life…
  • 2016 International Congress

    Dopaminergic and metabolic network activities in onset-related subtypes of Parkinson’s disease: A dual-tracer positron emission tomography study

    F.T. Liu, J.J. Ge, J.J. Wu, Z.T. Ding, C.T. Zuo, J. Wang (Shanghai, People's Republic of China)

    Objective: The current study investigated the differences of dopaminergic and metabolic patterns between the young-onset subtype of Parkinson's disease (YOPD) and the late-onset subtype (LOPD)…
  • 2016 International Congress

    Quality of life and living with Parkinson’s in Ireland

    I. Cassidy, P. Meskell, M.P. Butler, M. Richardson, C. Kennedy, S. Coote, P. Boers (Limerick, Ireland)

    Objective: (1) Assess the quality of life (QoL) for people with Parkinson's and explore associations between (QoL) and demographics (2) Investigate incidence of depression and…
  • 2016 International Congress

    Tracking Parkinson’s disease over 2-6 years with MRI

    T.R. Melzer, D.J. Myall, M.R. MacAskill, L. Livingston, T.L. Pitcher, K. Wood, R.J. Keenan, J.C. Dalrymple-Alford, T.J. Anderson (Christchurch, New Zealand)

    Objective: To track Parkinson's progression over 2-6 years using global MRI measures. Background: Parkinson's is associated with accelerated brain atrophy, but the relative contribution of…
  • 2016 International Congress

    Broadening the evaluative scope of quality of life in Parkinson’s: Testing the construct validity of the ICECAP-O instrument

    Y. Xin, J. Lewsey, R. Gray, C.E. Clarke, E. McIntosh (Glasgow, United Kingdom)

    Objective: To test the construct validity of ICECAP-O in Parkinson's and explore its relationship with the EQ-5D and the PDQ-39. Background: Parkinson's significantly affects patients'…
  • 2016 International Congress

    Gait and cognition: Mapping the global and discrete relationships in ageing and neurodegenerative disease

    R. Morris, S. Lord, J. Bunce, D. Burn, L. Rochester (Newcastle-Upon-Tyne, United Kingdom)

    Objective: To explore current evidence of associations and predictors of gait and cognition in older adults and pathology to provide a clear understanding of current…
  • 2016 International Congress

    Measuring interdependence of the health status of people with Parkinson’s disease and their spouses

    F. Noubary, S.D. Gunnery, E.M. Naumova, M. Saint-Hilaire, C.A. Thomas, L. Tickle-Degnen (Boston, MA, USA)

    Objective: To demonstrate an innovative visualization method for measuring the interdependence of the health status of people with Parkinson's disease (PD) and their spouses over…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 24
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley